The Bio-Technopark Schlieren-Zurich, in close collaboration with its network partners, offers professional support for life science companies in the setting up and expansion of business activities in the Greater Zurich Area.
ETH Zurich and the University of Zurich are flagging up an impressive number of spin-off establishments in the life sciences. Experience shows that start-up firms locate in the vicinity of their particular knowledge base. There is a healthy spread of firms at varying stages of business development in Schlieren, which range from recent start-ups to global players. In 2003 these firms joined forces in the non-profit organization formerly named Biotech Center Zurich with the owner of the Wagi site, the city of Schlieren and the Canton of Zurich’s Department for Economic Development in order to simplify both their internal and external communication and to identify and maximize synergies.
In 2010 the center changed its name to Bio-Technopark Schlieren-Zurich to closely co-operate, within the terms of a license and co-operation agreement for the promotion of business start-ups, with the TECHNOPARK Zurich Foundation.
Bio-Technopark Schlieren-Zurich hit the headlines with the sale of the young start-up Glycart to Roche for 235 million CHF in 2005, and also 2009 on the takeover of ESBATech by Alcon, the US ophthalmological company for about 600 million USD.
- Providing laboratory, office and special-purpose infrastructure facilities
- Advice and support in the establishment of companies and in fundraising
- Ongoing coaching in business development
- Support of the exchange between start-ups for the identification and maximizing of synergies
- Providing contacts between members, established companies, universities and network partners
- Professional support for the locational support authorities in the settlement of foreign enterprises
- Organization of events
- Supporting members in the field of PR and lobbying
Phone: +41 (0)44 730 83 29
Mobile: +41 (0)76 336 99 44
Email to Mario Jenni